PEGLIDOX 20mg (Liposomal Doxorubicin Vials) 20mg

PEGLIDOX 20mg is a liposomal doxorubicin formulation in vial form, designed for cancer treatment. This targeted therapy delivers chemotherapy with reduced side effects compared to standard doxorubicin. Ideal for patients seeking effective cancer care with minimized cardiac risks.

Strength

20mg

Manufacturer / TM Owner

GLS Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PEGLIDOX 20mg is used to treat various cancers including breast cancer, ovarian cancer, and Kaposi's sarcoma. It belongs to a class of medications called anthracyclines, which work by slowing or stopping cancer cell growth. Patients often ask what is PEGLIDOX 20mg used for, and it is primarily prescribed for chemotherapy regimens.

Side Effects

PEGLIDOX 20mg may cause common effects like nausea, fatigue, or hair thinning. Some patients experience mouth sores or changes in blood cell counts. These effects vary by individual and treatment duration. Liposomal delivery aims to reduce severe side effects compared to conventional doxorubicin.

Precautions & Warnings

Handle PEGLIDOX 20mg with care as it is a chemotherapy agent. Avoid contact with skin or mucous membranes; use protective gloves when handling vials. Store vials at controlled room temperature, away from light and moisture. Always follow healthcare provider instructions for safe administration.

Avoid Interactions

PEGLIDOX 20mg may interact with other chemotherapy drugs or medications affecting liver enzymes. Avoid alcohol and grapefruit products during treatment. Certain vaccines may have reduced effectiveness while on this medication. Always inform your doctor about all medications and supplements you are taking.

Frequently Asked Questions

PEGLIDOX 20mg is used to treat certain cancers like breast cancer, ovarian cancer, and Kaposi's sarcoma as part of chemotherapy.

PEGLIDOX 20mg is given as an intravenous infusion by healthcare professionals in a clinical setting.

Common side effects may include nausea, fatigue, hair thinning, and changes in blood cell counts.

No, always use protective gloves when handling PEGLIDOX 20mg vials to avoid skin contact.

PEGLIDOX 20mg uses liposomal technology which may reduce some side effects like heart toxicity compared to standard doxorubicin.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.